Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M94,506Revenue (TTM) $M15,767Net Margin (%)28.1Altman Z-Score1.1
Enterprise Value $M138,508EPS (TTM) $10.1Operating Margin %-16.0Piotroski F-Score6
P/E(ttm)23.6Beneish M-Score-2.8Pre-tax Margin (%)-23.6Higher ROA y-yY
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio0.9Cash flow > EarningsY
Price/Sales5.95-y EBITDA Growth Rate %-8.2Current Ratio1.0Lower Leverage y-yY
Price/Free Cash Flow19.7y-y EBITDA Growth Rate %451ROA % (ttm)3.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)5.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M396ROIC % (ttm)-1.3Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGNDavid Tepper 2016-06-30 Add5.96%$201.65 - $277.55
($231.14)
$ 238.683%Add 351.73%1,260,809
AGNCarl Icahn 2016-06-30 Buy 3.88%$201.65 - $277.55
($231.14)
$ 238.683%New holding3,400,000
AGNJohn Paulson 2016-06-30 Reduce-2.98%$201.65 - $277.55
($231.14)
$ 238.683%Reduce -27.13%3,948,451
AGNWallace Weitz 2016-06-30 Add2.53%$201.65 - $277.55
($231.14)
$ 238.683%Add 95.58%595,961
AGNSteve Mandel 2016-06-30 Sold Out -2.39%$201.65 - $277.55
($231.14)
$ 238.683%Sold Out0
AGNRuane Cunniff 2016-06-30 Reduce-2.13%$201.65 - $277.55
($231.14)
$ 238.683%Reduce -99.67%3,435
AGNDavid Einhorn 2016-06-30 Sold Out -1.99%$201.65 - $277.55
($231.14)
$ 238.683%Sold Out0
AGNRobert Bruce 2016-06-30 Buy 1.64%$201.65 - $277.55
($231.14)
$ 238.683%New holding25,000
AGNSeth Klarman 2016-06-30 Add0.88%$201.65 - $277.55
($231.14)
$ 238.683%Add 16.29%2,001,978
AGNPrivate Capital 2016-06-30 Reduce-0.82%$201.65 - $277.55
($231.14)
$ 238.683%Reduce -15.09%137,319
AGNLeon Cooperman 2016-06-30 Add0.72%$201.65 - $277.55
($231.14)
$ 238.683%Add 19.59%671,212
AGNGeorge Soros 2016-06-30 Reduce-0.47%$201.65 - $277.55
($231.14)
$ 238.683%Reduce -43.65%80,735
AGNVanguard Health Care Fund 2016-06-30 Add0.43%$201.65 - $277.55
($231.14)
$ 238.683%Add 7.85%12,066,307
AGNFirst Eagle Investment 2016-06-30 Sold Out -0.25%$201.65 - $277.55
($231.14)
$ 238.683%Sold Out0
AGNMario Gabelli 2016-06-30 Add0.03%$201.65 - $277.55
($231.14)
$ 238.683%Add 53.06%60,913
AGNRon Baron 2016-06-30 Reduce-0.02%$201.65 - $277.55
($231.14)
$ 238.683%Reduce -48.96%13,923
AGNJoel Greenblatt 2016-06-30 Add0.02%$201.65 - $277.55
($231.14)
$ 238.683%Add 42.89%20,529
AGNKen Fisher 2016-06-30 Add$201.65 - $277.55
($231.14)
$ 238.683%Add 11.44%3,594
AGNSeth Klarman 2016-03-31 Buy 6.72%$266.3 - $312.5
($286.72)
$ 238.68-17%New holding1,721,587
AGNSteve Mandel 2016-03-31 Buy 2.39%$266.3 - $312.5
($286.72)
$ 238.68-17%New holding1,789,239
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Basgoz NesliDirector 2016-08-05Sell758$253.02-5.67view
Hilado Maria TeresaCFO 2016-06-02Buy661$241.57-1.2view
Basgoz NesliDirector 2016-05-11Sell459$225.16.03view
Basgoz NesliDirector 2015-12-07Sell2,300$312.96-23.73view
BISARO PAULExec Chairman 2015-08-24Buy1,000$297.42-19.75view
SAUNDERS BRENT LCEO and President 2015-08-21Buy1,000$301.94-20.95view
Basgoz NesliDirector 2015-06-09Sell2,200$297.89-19.88view
Meury WilliamSee Remarks 2014-11-26Sell4,550$269.14-11.32view
PAONESSA ALBERT IIIPresident Anda, Inc. 2014-09-08Sell6,642$230.493.55view
Hindman James M.EVP, Finance & Bus. Dev., CFO 2014-08-18Sell0$03.55view

Press Releases about AGN :

Quarterly/Annual Reports about AGN:

News about AGN:

Articles On GuruFocus.com
Wallace Weitz's Largest 2nd-Quarter Trades Sep 22 2016 
Jeff Auxier Buys Biogen, LyondellBasell and Union Pacific Sep 19 2016 
RS Investments Buys Allergan, Integra Lifesciences Sep 15 2016 
Robert Bruce Invests in Allergan in 2nd Quarter Sep 07 2016 
Allergan: An Undervalued Powerhouse Aug 28 2016 
Hedge Funds Love Liberty and John Malone Aug 26 2016 
Which Criteria Best Determine the Success of Mergers? Aug 24 2016 
Carl Icahn Buys Allergan Aug 22 2016 
Steve Mandel Buys Shire, Axes 6 Positions in 2nd Quarter Aug 17 2016 
David Tepper Raises Bet on Allergan and Adds 2 New Positions in Latest Quarter Aug 15 2016 

More From Other Websites
Unexpected Twist: Pfizer Scraps Breakup Following Dead Allergen Merger Sep 26 2016
Drugmaker Pfizer decides not to break up business Sep 26 2016
Drugmaker Pfizer decides not to break up business Sep 26 2016
Read Scraps Pfizer Break-Up as Megadeals Escape Its Grasp Sep 26 2016
The Zacks Analyst Blog Highlights: Deutsche Bank, Apple, Therapeutics, Allergan and Gilead Sciences Sep 26 2016
Allergan Gets FDA Approval for New Line of Breast Implants Sep 26 2016
Pfizer decides against splitting into two companies Sep 26 2016
4:31 pm Allergan confirms FDA approval of Natrelle Inspira cohesive breast implants Sep 25 2016
Allergan Announces FDA Approval of NATRELLE INSPIRA® Cohesive Breast Implants Sep 23 2016
Allergan Announces FDA Approval of NATRELLE INSPIRA® Cohesive Breast Implants Sep 23 2016
Big trade buys time for gains in Allergan Sep 23 2016
[$$] US politicians lament inaction over price-gouging drug companies Sep 23 2016
Allergan/Adamas Launch New Dosage Strengths of Namzaric Sep 23 2016
Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO Sep 23 2016
Saluting Biotech M&A: Onward And Upward Sep 23 2016
Allergan's Vitae Buy Could Spark More Interest in Kadmon Sep 23 2016
New highs: What's left to buy? Sep 22 2016
Gilead, Allergan Seen Trailing Intercept In Ongoing NASH Battle Sep 22 2016
Will Gilead Make a Good Fit for Allergan? (GILD) Sep 22 2016
Gilead Sciences (GILD) Stock Lower Despite Bullish Gabelli Note Sep 22 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)